Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ADMA

ADMA BIOLOGICS, INC.

CIK 0001368514 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$9.27
↑ 0.11 (1.20%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Options

Key stats

Market Cap
$2.15B
P/E Ratio
12.99
EPS
0.62
Dividend Yield
Not covered
52W Position
16%
Beta
0.92

Valuation multiples

Fwd P/E
10.79
PEG
0.00
P/B
5.50
P/S
4.21
EV/Revenue
4.33
ROE
42.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 16%
$7.21$20.46

Latest Financials

2025-12-31 FY
Revenue
$510.17M
Net Income
$146.93M
Total Assets
$624.24M
Free Cash Flow
$27.82M

Recent news